Maverick Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,187	Closed	-$504K	–	380
2024 Q1	$504K	Buy	+4,187	New	+$513K	0.01%	218
2021 Q4	–	Sell	-10,120	Closed	-$1.32M	–	482
2021 Q3	$1.32M	Sell	10,120 -15,738	-61%	-$2.38M	0.01%	235
2021 Q2	$4.59M	Buy	25,858 +7,329	+40%	+$1.27M	0.04%	100
2021 Q1	$3.05M	Buy	18,529 +9,480	+105%	+$1.56M	0.03%	107
2020 Q4	$1.49M	Buy	+9,049	New	+$1.35M	0.02%	174
2019 Q2	–	Sell	-39,040	Closed	-$5.58M	–	316
2019 Q1	$5.58M	Buy	39,040 +1,590	+4%	+$207K	0.07%	177
2018 Q4	$4.64M	Buy	37,450 +570	+2%	+$84.6K	0.07%	194
2018 Q3	$6.2M	Sell	36,880 -5,030	-12%	-$865K	0.08%	147
2018 Q2	$7.22M	Sell	41,910 -20,450	-33%	-$3.34M	0.08%	129
2018 Q1	$9.42M	Buy	62,360 +18,820	+43%	+$2.76M	0.12%	106
2017 Q4	$5.86M	Buy	43,540 +21,760	+100%	+$3.02M	0.07%	140
2017 Q3	$3.19M	Buy	21,780 +6,090	+39%	+$921K	0.04%	139
2017 Q2	$2.44M	Buy	15,690 +5,510	+54%	+$843K	0.03%	112
2017 Q1	$1.48M	Sell	10,180 -2,060	-17%	-$268K	0.02%	99
2016 Q4	$1.33M	Buy	12,240 +2,530	+26%	+$282K	0.02%	91
2016 Q3	$1.18M	Buy	9,710 +1,500	+18%	+$202K	0.01%	106
2016 Q2	$1.16M	Sell	8,210 -860	-9%	-$127K	0.02%	107
2016 Q1	$1.18M	Buy	+9,070	New	+$1.13M	0.02%	89